Nagmeldin Abuassa

4PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples epidemiologyMedical parasitologyMultimorbidity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 25, 2025
FDA approves durvalumab for muscle-invasive bladder cancer: a new standard in neoadjuvant and adjuvant therapy.

Ibrahim Nagmeldin Hassan, Muhsin Nagmeldin Hassan Ibrahim, Nagmeldin Abuassa

|Aug 25, 2025
Recurrent postcoital syncope due to a vagal response triggered by deep penetration: a case report.

Ibrahim Nagmeldin Hassan, Siddig Yaqub, Mohamed Ibrahim

|Apr 07, 2025
Strengthening the response to the monkeypox outbreak in Africa: addressing critical gaps and challenges.

Ibrahim Nagmeldin Hassan, Nagmeldin Abuassa, Mohamed Ibrahim

|Oct 24, 2024
Hypertension in the Shadows of Conflict: The Impact of the Sudan War on Blood Pressure Management.

Ibrahim Nagmeldin Hassan, Nagmeldin Abuassa, Mohamed Ibrahim

Pageof 1